ClinVar Miner

Submissions for variant NM_001182.5(ALDH7A1):c.1468del (p.Ala490fs)

dbSNP: rs796052267
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000186757 SCV000240324 pathogenic not provided 2013-03-04 criteria provided, single submitter clinical testing The c.1468delG variant in the ALDH7A1 gene causes a frameshift starting with codon Alanine 490, changes this amino acid to a Leucine residue and creates a premature Stop codon at position 28 of the new reading frame, denoted p.Ala490LeufsX28. This mutation is predicted to result in the replacement of the last 50 amino acids with 20 incorrect amino acids, leading to protein truncation. Although this pathogenic variant has not been previously reported to our knowledge, this result is consistent with a diagnosis of an ALDH7A1-related disorder. This variant has been observed to be apparently homozygous.
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute RCV003225038 SCV003921930 pathogenic Pyridoxine-dependent epilepsy 2022-07-01 criteria provided, single submitter clinical testing 0102 - Loss of function is a known mechanism of disease in this gene and is associated with epilepsy, pyridoxine-dependent (MIM#266100). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0205 - Variant is predicted to result in a truncated protein (premature termination codon is NOT located at least 54 nucleotides upstream of the final exon-exon junction) with less than 1/3 of the protein sequence affected. (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other downstream protein-truncating variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. At least four others have been reported in homozygous or compound heterozygous individuals with seizures (ClinVar, PMIDs: 30043187, 33748042). (SP) 0803 - This variant has limited previous evidence of pathogenicity in an unrelated individual. It has been reported in a homozygous individual with seizures (PMID: 29655203). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1005 - Clinically accredited laboratory assay specific to gene product shows abnormal protein function. Raised urinary piperideine-6-carboxylic was found in this individual. (SP) 1101 - Very strong and specific phenotype match for this individual. (SP) 1205 - This variant has been shown to be maternally inherited (by trio analysis). (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign
Genome-Nilou Lab RCV003225038 SCV004050095 pathogenic Pyridoxine-dependent epilepsy 2023-04-11 criteria provided, single submitter clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.